CIMNEERA
LIVE

Serial Number

79282192

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Feb 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CIMNEERA Trademark

Serial Number: 79282192 • Registration: 6144457

CIMNEERA is a trademark filed by NOVARTIS AG on February 13, 2020. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 13, 2020

Registration Date

September 8, 2020

Published for Opposition

May 26, 2020

Cancellation Date

October 13, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION REVIEWED - NO ACTION REQUIRED BY OFFICE
Nov 4, 2020 FINA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 1, 2020 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 1, 2020 DETH
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Oct 8, 2020 GPAR
REGISTERED-PRINCIPAL REGISTER
Sep 8, 2020 R.PR
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Aug 5, 2020 ETOP
EXTENSION OF TIME TO OPPOSE RECEIVED
Jun 24, 2020 ETOF
PUBLISHED FOR OPPOSITION
May 26, 2020 PUBO
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
May 6, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 6, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
May 6, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 6, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 6, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
May 6, 2020 COAR
NOTICE OF PUBLICATION
May 6, 2020 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 20, 2020 CNSA
ASSIGNED TO EXAMINER
Apr 15, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 11, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 7, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 4, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 2, 2020 REPR